PB 9 of 2013
 
Amendment determination under paragraph 98C(1)(b) of the National Health Act 19531
_____________________________________________________________________
 
 
I, KIM BESSELL, First Assistant Secretary (Acting), Pharmaceutical Benefits Division, Department of Health and Ageing, delegate of the Minister for Health, make this Instrument under paragraph 98C(1)(b) of the National Health Act 1953.
 
Dated 07 February 2013
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
KIM BESSELL
First Assistant Secretary (Acting)
Pharmaceutical Benefits Division
Department of Health and Ageing
 
 
 
1              Name of Instrument
(1)                This Instrument is the Amendment determination under paragraph 98C(1)(b) of the National Health Act 1953.
(2)                This Instrument may also be cited as PB 9 of 2013.
2              Commencement                                                        
                This instrument commences on 1 March 2013.
3              Amendments to Determination under paragraph 98C(1)(b) of the National Health Act 1953 (PB 119 of 2008)
                Schedule 1 amends the Determination under paragraph 98C(1)(b) of the National Health Act 1953 (PB 119 of 2008).
Schedule 1            Amendments
 
[1]        Schedule 4, after entry for Macrogol 3350 in the form Sachets containing powder for oral solution 13.125 g with electrolytes, 30
insert in the column headed “Form (strength, type, size, etc.):
 
Sachets containing powder for oral solution 17 g, 30
[2]        Schedule 4, after entry for Testosterone in the form Transdermal patches
24.3 mg, 30
insert in the column headed “Form (strength, type, size, etc.):
 
Transdermal solution (pump pack) 30 mg per 1.5 mL dose, 60 doses
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
1Note
All legislative instruments and compilations are registered on the Federal Register of Legislative Instruments kept under the Legislative Instruments Act 2003. 
See http://www.comlaw.gov.au.